Active Pharmaceutical IngredientFeaturedIP / EP / USP

Metformin HCI

Description

A biguanide that lowers blood glucose by reducing liver glucose production and improving insulin sensitivity. Remains the global first-line therapy for type 2 diabetes due to its reliability and safety profile.

Applications

Formulated into immediate-release and extended-release tablets, frequently combined with Sitagliptin, Glimepiride, or Empagliflozin.

Specifications

Therapeutic ClassDiabetes & Metabolic Health
AppearanceWhite Crystalline Powder
Assay / Purity98.0–101.0%
SolubilityFreely Soluble In Water
GradeIP / USP / EP
Manufacturing ComplianceWHO-GMP / EU-GMP / USFDA

Get a tailored quotation for Metformin HCI within 24 business hours.

Request QuoteWhatsApp Enquiry

Response within 24 business hours

RELATED PRODUCTS

View all
API

Rosuvastatin Calcium

A statin that lowers LDL cholesterol and raises HDL by inhibiting the HMG-CoA reductase enzyme in the liver.

Know More
API
Featured

Semaglutide

A GLP-1 receptor agonist that regulates blood sugar and suppresses appetite by mimicking a naturally occurring gut hormone.

Know More
API

Sitagliptin

A DPP-4 inhibitor that boosts insulin release and lowers glucagon by extending the activity of incretin hormones.

Know More